Clinical trial: levofloxacin‐based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant <i>Helicobacter pylori</i> infection
Y. K. Yee(University of Hong Kong), Bcy Wong, Man‐Fung Yuen(University of Hong Kong - Shenzhen Hospital), James Fung(University of Hong Kong), Ting Kin Cheung(Education University of Hong Kong), C. K. Chan(Queen Mary Hospital), Axel Hsu(University of Hong Kong), David But(Queen Mary Hospital), K.‐M. CHU(University of Hong Kong), P. Chan, Annie O.O. Chan, Ivan Fan‐Ngai Hung(Chinese University of Hong Kong)
Cited by 26
Related Papers
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis
|Gastroenterology|2020|1.7k
Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19
|Radiology|2020|1.5k
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing
|Clinical Infectious Diseases|2020|818
Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
|Clinical Infectious Diseases|2011|716
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
|Journal of Clinical Virology|2004|541